Abstract:Objective To evaluate and compare the antibody to hepatitis B virus (HBV) surface antigen (anti-HBs) response and the influent factors of revaccination of 4 kinds of hepatitis B vaccine (HepB) among firstly low-response adults.Methods A total of 11 590 adults who were 18-49 years old,never received HepB vaccination,without HBV infection history,HBs-Ag negative,and had been living at 3 towns of Zhangqiu county in Shandong province Ji'nan city for more than half a year,were selected in the study in July,2009.Self-designed questionnaire was used to select the basic information of the subjects.The subjects were divided into 4 groups by cluster sampling,and were vaccinated according to the "0-1-6"immune procedure with 10 μgHepB made by recombinant deoxyribonucleic acid techniques in Saccharomyces Cerevisiae (HepB-SC),10 μg HepB made by recombinant deoxyribonucleic acid techniques in Hansenula Polymorpha (HepB-HP),20 μg HepB-SC and 20 μg HepB made by recombinant dexyribonucleic acid techniques in Chinese hamster ovary cell (HepB-CHO),3 doses respectively.The adults who were low-response to the primary hepatitis B vaccination (10 mU/ml≤anti-HBs ＜ 100 mU/ml)were divided into four groups by cluster sampling.These groups were revaccinated with one-dose of above-mentioned four kinds of HepB respectively.Blood samples were drawn from each person one month after the revaccination.Anti-HBs was detected by chemiluminescence microparticle immunoassay and compared by the vaccine type.The influence factors about antibody response were also analyzed.Results Out of the 11 590 subjects,8592 adults had accepted the primary vaccination of hepatitis B and been collected the blood samples; among whom,1306 subjects showed low-response,at the rate of 15.20％A total of 1034 low-response subjects accepted secondary strengthened vaccination and were collected blood samples; 55.13％ of them showed anti-HBs seroconversion (anti-HBs ≥ 100 mU/ml ); while the seroeonversion rate in each group was 44.54％ (106/238) in 10 μg HepB-SC group,57.14％ (156/273)in 10 μg HepB-HP group,56.08％ (143/255) in 20 μg HepB-SC group and 61.57％ (165/268) in 20 μg HepB-CHO group,respectively.There was significant difference among the groups (X2=17.14,P ＜ 0.01 ).The rates of anti-HBs seroconversion were significantly higher in 10 μg HepB-HP and 20 μg HepB-CHO groups than it in 10 μg HepB-SC group ( X2 were 8.09 and 14.70 respectively,P ＜ 0.01 ).The geometric mean concentration (GMC) of anti-HBs was 178.24 mU/ml among the low-responders after one dose of revaccination.The GMC was 109.77,243.50,144.98 and 242.83 mU/ml in 10 μg HepB-SC group,10 μg HepB-HP group,20 μg HepB-SC group and 20 μg HepB-CHO group,respectively.There was significant difference among groups ( F =9.52,P ＜ 0.01 ).Conclusion Anti-HBs response could be strengthened effectively after one-dose of HepB revaccination among the low-response adults.Many factors like the vaccine typs could effect the immune effects to HepB.A better response could be achieved if the 20 μg HepB-CHO or 10 μg HepB-HP was used for revaccination.

The Response of Hepatitis B Vaccination on Seronegative Adults with Different Vaccination Schedules.

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Factors influencing immunologic response to hepatitis B vaccine in adults

Optimal Vaccination Program For Healthy Adults In China

Suitable Hepatitis B Vaccine for Adult Immunization in China

The Two-years Immune Effect Between 0-1-2-months and 0-1-6-months of HBV Vaccination Schedule in Adults

Responses to Hepatitis B Vaccine in Isolated Anti-Hbc Positive Adults.

Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis.

Strategies for Hepatitis B Booster Vaccination among Children: an 8-Year Prospective Cohort Study

Immunological Effects of a 10-Μg Dose of Domestic Hepatitis B Vaccine in Adults

Effects of hepatitis B vaccine boosters on anti-HBs-negative children after primary immunization.

Long-term Persistence of Anti-Hbs after Hepatitis B Vaccination among Isolated Anti-Hbc Positive Adults in China: 8-Years Results

Comparison of Anti-Hbs Persistence after Hepatitis B Vaccination on Two-Dose Schedule and Three-Dose Schedule among Adults: Results from a 12-Year Follow Up Study in China

Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults

[Matching Study on Immune Response Between Single Anti-Hbc Positivity and Healthy Adults after Primary Immunization and Revaccination of Hepatitis B Vaccine].

Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults

Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province:24-month of follow-up from 2009

The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: a 5-year follow-up study.

The One Year Effects of Three Doses of Hepatitis B Vaccine As a Booster in Anti-Hbs-negative Children 11–15 Years after Primary Immunization; China, 2009–2011

[Serum Antibody Response to Different Doses of Hepatitis B Vaccine Made by Recombinant DNA Techniques in Yeast and Hansenula Polymorpha Yeast].

Survey of Hepatitis B Vaccination Coverage and Surface Antibody-Positive Rates in People Aged 1-59 Years in 2006 and 2024